Literature DB >> 19343263

The synthesis of new oxazoline-containing bifunctional catalysts and their application in the addition of diethylzinc to aldehydes.

Vincent Coeffard1, Helge Müller-Bunz, Patrick J Guiry.   

Abstract

The straightforward preparation of new modular oxazoline-containing bifunctional catalysts is reported employing a microwave-assisted Buchwald-Hartwig aryl amination as the key step. Covalent attachment of 2-(o-aminophenyl)oxazolines and pyridine derivatives generated in good-to-high yields a series of ligands in two or three steps in which each part was altered independently to tune the activity and the selectivity of the corresponding catalysts. These catalysts prepared in situ were subsequently applied in the asymmetric addition of diethylzinc to various aldehydes, producing the corresponding alcohols with enantioselectivities of up to 68%. A transition state model, based on relevant X-ray crystal structures, has also been proposed to explain the observed stereoselectivities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343263     DOI: 10.1039/b822580j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  2-(3-Chloro-5,6-diphenyl-2,5-dihydro-1,2,4-triazin-5-yl)-2-methyl-propane-nitrile.

Authors:  Ewa Wolińska; Zbigniew Karczmarzyk; Andrzej Rykowski; Zofia Urbańczyk-Lipkowska; Przemysław Kalicki
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-31

2.  N-{2-[(4S)-4-tert-Butyl-4,5-dihydro-1,3-oxazol-2-yl]phen-yl}-5,6-diphenyl-1,2,4-triazin-3-amine.

Authors:  Zbigniew Karczmarzyk; Ewa Wolińska; Andrzej Fruziński
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-19

3.  Synthesis and crystal structures of tetra-meric [2-(4,4-dimethyl-2-oxazolin-2-yl)anilido]sodium and tris-[2-(4,4-dimethyl-2-oxazolin-2-yl)anilido]ytterbium(III).

Authors:  Leah Gajecki; Brendan Twamley; David J Berg
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2020-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.